Home > News > BioSante Pharmaceuticals Announces 2003 Key Achievements
March 9th, 2004
BioSante Pharmaceuticals Announces 2003 Key Achievements
Abstract:
BioSante Pharmaceuticals (Amex:BPA) today announced key achievements and financial results for the year ended December 31, 2003. "We are quite pleased with our achievements and progress in the last year. Recent FDA actions and hormone therapy market indications are very encouraging," said Stephen M. Simes, president and chief executive officer of BioSante. "The most exciting recent event affecting the estrogen market is the FDA's approval of an estrogen gel developed by Solvay Pharmaceuticals, Inc.
Source:
Businesswire
Bookmark:
| Related News Press |
Financial Reports
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||